Friedenthal Financial bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,067 shares of the company’s stock, valued at approximately $978,000.
Several other large investors have also made changes to their positions in HCA. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter worth about $29,000. Palisade Asset Management LLC purchased a new position in HCA Healthcare in the 3rd quarter worth approximately $26,000. Ares Financial Consulting LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at approximately $31,000. MCF Advisors LLC lifted its holdings in shares of HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after buying an additional 49 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA was highlighted as a top value stock for long-term investors, reinforcing the view that the shares may be attractive based on fundamentals and valuation. Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
- Positive Sentiment: TriStar, part of HCA, received a certificate of need to build a freestanding emergency room in Lebanon, which supports continued facility expansion and local growth. TriStar gains certificate of need to build freestanding ER in Lebanon
- Positive Sentiment: HCA Healthcare Foundation awarded $2.1 million in grants to 89 Middle Tennessee nonprofits, reinforcing community ties and brand goodwill in a core market. 89 Middle Tennessee nonprofits awarded $2.1M in grants by HCA Healthcare Foundation
- Neutral Sentiment: HCA sold 31 home health and hospice agencies, and DAI is acquiring 24 home health agencies from HCA, suggesting ongoing portfolio reshaping but not an obviously major earnings catalyst. HCA sells 31 home health, hospice agencies DAI To Acquire 24 Home Health Agencies From HCA, ‘Doubling Down’ On Care In The Home
- Neutral Sentiment: Coverage on the Frist family and HCA’s history, along with the naming of a new hospital CEO and a healthcare CEO pay list, is largely informational and unlikely to move the stock by itself. Frist family letter reveals the values that built HCA Healthcare by Dr. Thomas Frist Sr. HCA HealthONE names CEO of 2 Denver hospitals 23 highest-paid healthcare CEOs: Wall Street Journal
- Negative Sentiment: HCA’s chief clinical officer is set to exit after four years, creating some leadership turnover at the company. HCA’s chief clinical officer to exit after 4 years
HCA Healthcare Price Performance
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the business earned $6.45 earnings per share. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.
Wall Street Analyst Weigh In
HCA has been the subject of several research reports. Royal Bank Of Canada dropped their price objective on shares of HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating for the company in a report on Monday, April 27th. KeyCorp dropped their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company reduced their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating on the stock in a research note on Monday, April 27th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Finally, Sanford C. Bernstein decreased their price target on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $503.00.
View Our Latest Stock Report on HCA
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
